SYNERGISTIC EFFECT OF PROBIMANE ON ANTICANCER CYTOTOXICITY OF DOXORUBICIN IN-VITRO

被引：0

作者：

ZHANG, Y

YE, QX

LIU, J

ZHANG, ZY

ZHANG, TM

机构：

来源：

ACTA PHARMACOLOGICA SINICA | 1994年 / 15卷 / 01期

关键词：

DOXORUBICIN; PROBIMANE; MALONDIADEHYDE; CULTURED TUMOR CELLS; DRUG SYNERGISM;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Using 3-(4,5-dimethythiazole)-2,5-diphenyltetrazolium bromide (MTT) method, the effect of probimane (Pro) on doxorubicin (Dox) cytotoxicity was studied. Pro 0.313, 0.625, and 1.25 mug.ml-1 potentiated cytotoxicity of Dox in Ehrlich ascites carcinoma (EAC) cells. Incubation of EAC cells with Dox 10 mug-ml-1 and Pro 116.5, 233, and 466 mug-ml-1 resulted in an increase in intracellular drug accumulation from 0.69 +/- 0.06 to 1.08 +/- 0.10 mug/10(7) cells. In S-37-bearing mice, Pro 23. 3, 46.6, and 116.5 mug . ml-1 enhanced the malondialdehyde (MDA) formation in tumor and liver mitochondria and decreased MDA formation in liver mitochondria. These results suggested that the increases of Dox accumulation and MDA formation in tumor cells by Pro might be the reasons for synergistic effect of Pro on Dox cytotoxicity.

引用

页码：56 / 59

页数：4

共 50 条

[41] In-vitro cytotoxicity, synergistic antibacterial activity and interaction studies of imidazolium-based ionic liquids with levofloxacin
Siddiquee, Md Abrar
Saraswat, Juhi
Imtiyaz, Khalid
Bhat, Ab Raouf
Wani, Farooq Ahmad
Alanazi, Amer M.
Khan, Azmat Ali
Rizvi, M. Moshahid Alam
Patel, Rajan
JOURNAL OF MOLECULAR LIQUIDS, 2021, 325
[42] Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro
Lundgren-Eriksson, L
Hultborn, R
Henriksson, R
ANTICANCER RESEARCH, 2001, 21 (05) : 3275 - 3280
[43] The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect
Barbalata, Cristina-Ioana
Porfire, Alina Silvia
Casian, Tibor
Muntean, Dana
Rus, Iulia
Tertis, Mihaela
Cristea, Cecilia
Pop, Anca
Cherfan, Julien
Loghin, Felicia
Tomuta, Ioan
PHARMACEUTICALS, 2022, 15 (10)
[44] The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics
Deng, Yuxia
Zhang, Haijun
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 1835 - 1841
[45] In-vitro cytotoxicity, in-vivo biodistribution and antitumour effect of PEGylated liposomal topotecan
Hao, YL
Deng, YJ
Chen, Y
Wang, KZ
Hao, AJ
Zhang, Y
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (10) : 1279 - 1287
[46] IN-VITRO EVALUATION OF ANTIBACTERIAL ACTIVITY AND CYTOTOXICITY EFFECT OF CHEMICALLY SYNTHESIZED ZnO NANOPARTICLE
Renugadevi, K.
Raji, P.
Bavanilatha, M.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (08): : 2639 - 2643
[47] ADVERSE EFFECT OF ANTICANCER AGENT ON PRIMARY CULTURED HUMAN CANCER CELLS IN-VITRO
ORITA, K
SUHARA, G
KOKUMAI, Y
ACTA MEDICA OKAYAMA, 1972, 26 (1-2) : 51 - 55
[48] Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Jalali, Fereshtehsadat
Fakhari, Fatemeh
Sepehr, Afrah
Zafari, Jaber
Sarajar, Behnam Omidi
Sarihi, Pouria
Jafarzadeh, Emad
TRANSLATIONAL ONCOLOGY, 2024, 45
[49] CYTOTOXICITY OF HUMAN LYMPHOCYTES CAUSED BY ANTIBODIES IN-VITRO
MANNI, JA
PATRUCCO, A
BRACCO, MDED
MEDICINA-BUENOS AIRES, 1973, 32 (06) : 719 - 720
[50] Design and synthesis of novel quinic acid derivatives: in vitro cytotoxicity and anticancer effect on glioblastoma
Murugesan, Akshaya
Holmstedt, Suvi
Brown, Kenna C.
Koivuporras, Alisa
Macedo, Ana S.
Nguyen, Nga
Fonte, Pedro
Rijo, Patricia
Yli-Harja, Olli
Candeias, Nuno R.
Kandhavelu, Meenakshisundaram
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (21) : 1891 - 1910

← 1 2 3 4 5 →